{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:05:26Z","timestamp":1791198326633,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/inf.0b013e3182814b30","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T10:12:51Z","timestamp":1355825571000},"page":"e254-e262","source":"Crossref","is-referenced-by-count":4,"title":["Biceps Skin-fold Thickness May Detect and Predict Early Lipoatrophy in HIV-infected Children"],"prefix":"10.1097","volume":"32","author":[{"given":"Steve","family":"Innes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schulte-Kemna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard Werner","family":"Z\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Haubrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Klinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair","family":"Edson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"van Niekerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Ryan","family":"Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-17-20210202","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"AIDS Clinical Trials Group (ACTG) A5142 Study Team. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS"},{"key":"R5-17-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/QAI.0b013e31816856ed","article-title":"Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine.","volume":"48","author":"Shlay","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-17-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","article-title":"Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.","volume":"40","author":"Beregszaszi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-17-20210202","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000230523.94588.85","article-title":"Body fat changes and lipodystrophy in HIV-infected children: impact of highly active antiretroviral therapy.","volume":"43","author":"Dzwonek","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-17-20210202","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/QAI.0b013e31824330cb","article-title":"Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors Fat abnormality in children.","volume":"59","author":"Alam","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-17-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2431-12-183","article-title":"High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.","volume":"12","author":"Innes","year":"2012","journal-title":"BMC Pediatrics"},{"key":"R10-17-20210202","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"HIV Lipodystrophy Case Definition Study Group. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study.","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"R12-17-20210202","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4274\/jcrpe.v1i4.3","article-title":"Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management.","volume":"1","author":"Berberoglu","year":"2009","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"R14-17-20210202","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/135965350701200811","article-title":"Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.","volume":"12","author":"Aurpibul","year":"2007","journal-title":"Antivir Ther (Lond)"},{"key":"R15-17-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.inf.0000215003.32256.aa","article-title":"Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy.","volume":"25","author":"Hartman","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R18-17-20210202","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0272989X8900900307","article-title":"Analyzing a portion of the ROC curve.","volume":"9","author":"McClish","year":"1989","journal-title":"Med Decis Making"},{"key":"R19-17-20210202","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1049732307311118","article-title":"Disclosure of HIV status: experiences and perceptions of persons living with HIVAIDS and nurses involved in their care in Africa.","volume":"18","author":"Greeff","year":"2008","journal-title":"Qual Health Res"},{"key":"R21-17-20210202","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/09540120500456193","article-title":"Management of HIV-related stigma and adherence to HAART. evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).","volume":"18","author":"Peretti-Watel","year":"2006","journal-title":"AIDS Care"},{"key":"R22-17-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10461-008-9444-7","article-title":"Self-perception of body fat changes and HAART adherence in the Womens Interagency HIV Study.","volume":"13","author":"Plankey","year":"2009","journal-title":"AIDS Behav"},{"key":"R23-17-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11904-006-0021-2","article-title":"Caring for adolescents with HIV.","volume":"3","author":"DeLaMora","year":"2006","journal-title":"Curr HIVAIDS Rep"},{"key":"R24-17-20210202","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/INF.0b013e31823f0e11","article-title":"Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.","volume":"31","author":"Aurpibul","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R25-17-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2431-12-183","article-title":"High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: A cross-sectional study.","volume":"12","author":"Innes","year":"2012","journal-title":"BMC Pediatrics"},{"key":"R26-17-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Mitochondrial Toxicity (MITOX) Study Group. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"R27-17-20210202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/135965350701200303","article-title":"Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz.","volume":"12","author":"Vigano","year":"2007","journal-title":"Antivir Ther (Lond)"},{"key":"R28-17-20210202","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/AAC.00914-09","article-title":"Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors.","volume":"54","author":"Stankov","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R30-17-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GIM.0b013e3181632713","article-title":"IL-1beta (3954CT) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.","volume":"10","author":"Asensi","year":"2008","journal-title":"Genet Med"},{"key":"R31-17-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/650003","article-title":"Association between HLA-B4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen.","volume":"50","author":"Wangsomboonsiri","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R32-17-20210202","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/QAD.0b013e32830b3a96","article-title":"Icona Foundation Study Group. Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.","volume":"22","author":"Zanone Poma","year":"2008","journal-title":"AIDS"},{"key":"R33-17-20210202","first-page":"369","article-title":"Static and dynamic differences among five types of skinfold calipers.","volume":"62","author":"Schmidt","year":"1990","journal-title":"Hum Biol"},{"key":"R34-17-20210202","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/03014467600001451","article-title":"Weight and skinfold variation at menarche and the critical body weight hypothesis.","volume":"3","author":"Cameron","year":"1976","journal-title":"Ann Hum Biol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e3182814b30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T21:33:51Z","timestamp":1687901631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201306000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182814b30","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}